Hormonstimulering inför IVF

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M, Zegers-Hochschild F, Saunders H, Alam V; CONSORT study group.
Reprod Biomed Online. 2009 Feb; 18(2):195-204

Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.
Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG.,
J Clin Endocrinol Metab. 2002 Feb; 87(2):709-1

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.
Wikland M., Bergh C., Borg K., Hillensjö., Howles C.M., Knutsson A., Nilsson L., Wood M.
Human Reprod. 2001, 16:1676-81

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.
Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, ItskovitzEldor J.
Hum. Reprod. 1999 Sep; 14(9):2242-4

IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
Bjercke S, Fedorcsak P, Åbyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
Hum Reprod 20: 2441-7, 2005.